Page 1

Biocon Limited - Product Pipeline Review - 2016


Description: The report provides comprehensive information on the therapeutics under development by Biocon Limited, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Request a sample of this report @ . Report Highlights Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Browse the complete report @ . Scope - The report provides a snapshot of the pipeline therapeutic landscape of Biocon Limited

- The report provides overview of Biocon Limited including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Biocon Limited’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Biocon Limited’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to buy - Evaluate Biocon Limited’s strategic position with total access to detailed information on its 2

product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Biocon Limited If you have any enquiry before buying a copy of this report @ .

List of Figures Biocon Limited - Pipeline by Top 10 Indication, 2016 7 Biocon Limited - Pipeline by Stage of Development, 2016 9 Biocon Limited - Monotherapy Products in Pipeline, 2016 10 Biocon Limited - Partnered Products in Pipeline, 2016 11 Biocon Limited - Pipeline by Target, 2016 36 Biocon Limited - Pipeline by Route of Administration, 2016 38 Biocon Limited - Pipeline by Molecule Type, 2016 39 Biocon Limited - Pipeline Products by Mechanism of Action, 2016 40 Contact for more information. About Us: Orbis Research ( is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients. Contact Us: Hector Costello Senior Manager – Client Engagements 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A. Phone No.: +1 (214) 884-6817; +912064101019 Follow Us on LinkedIn: Follow us on Twitter: Like us on Facebook: 3

2016 Biocon Limited- Drug Company Product Pipeline Review  

The report provides comprehensive information on the therapeutics under development by Biocon Limited, complete with analysis by stage of de...

Read more
Read more
Similar to
Popular now
Just for you